Qingmu Tec Co., Ltd.
301110
Youkeshu Technology
300209
Shenzhen Sunwin Intelligent
300044
Tianjin Pengling Group
300375
Wuxi Xinhongye Wire & Cable
301310
CN Stock MarketDetailed Quotes
002390 Guizhou Xinbang Pharmaceutical
- 4.18
- +0.03+0.72%
Pre-Opening Auction Dec 23 09:30 CST
8.13BMarket Cap37.32P/E (TTM)
0.00High0.00Low0lotVolume0.00Open4.15Pre Close0.00Turnover0.00%Turnover Ratio28.24P/E (Static)1.94BShares4.6852wk High1.20P/B7.74BFloat Cap2.8352wk Low4.57Limit Up1.85BShs Float26.35Historical High3.74Limit Down0.00%Amplitude1.47Historical Low0.09Dividend TTM--Avg Price0lotAsk2.15%Div YieldTTM100Lot Size0lotBid
Guizhou Xinbang Pharmaceutical Key Stats
EPS
According to the latest financial report of Guizhou Xinbang Pharmaceutical, the latest earnings per share (TTM) for the company is 0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Guizhou Xinbang Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 3.49.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Guizhou Xinbang Pharmaceutical shows that the company's current ratio is 2.92, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Guizhou Xinbang Pharmaceutical, the quick ratio is 2.40, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Guizhou Xinbang Pharmaceutical? The latest ROE figure is 2.59%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Guizhou Xinbang Pharmaceutical, the total asset return on investment (ROA) is 2.57%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Guizhou Xinbang Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 18.42%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Guizhou Xinbang Pharmaceutical, the net profit margin is 5.10%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.